In order to elucidate the mechanisms of reduction of serum thyroid hormones caused by continuous administration of kojic acid (KA) and its thyroid tumor-promotion effects, male F344 rats were given pulverized basal diet containing 0.008%, 0.03%, 0.125%, 0.5%, or 2% KA for 4 weeks. As an untreated control group, additional rats were given basal diet alone for the same period. The thyroid 125 I uptake was significantly decreased in the groups receiving 0.03% or more. In addition, significant reduction of organic formation of iodine and serum T3 and T4 levels were observed in the 2% KA group along with pronounced elevation of serum (TSH). Both absolute and relative thyroid weights were significantly increased in the groups receiving 0.5% of KA or more. Histopathologically, decreased colloid in the thyroid follicles and follicular cell hypertrophy in the thyroid were apparent at high incidences in the groups given 0.03% or more. In addition, thyroid capsular fibrosis was evident in all rats of the 2% KA group. In quantitative morphometrical analysis, the ratio of the area of follicular epithelial cells to the area of colloids was significantly increased in the groups given 0.03% KA or more. The results suggest that KA alteration of thyroid-related hormone levels in the 2% KA group are due to inhibition of iodide uptake and iodine organification in the thyroid, with tumor-promoting effects on development of thyroid proliferative lesions, probably secondary to prolonged serum TSH stimulation resulting from negative feedback through the pituitary-thyroid axis.
Kojic acid (5-hydroxy-2-(hydroxymethyl)-4-pyrone) is a secondary fungal metabolite (Cole and Cox, 1981; Morton et al., 1945) commonly produced by many species of Aspergillus, Acetobactor and Penicillium (Parrish et al., 1956) . Of these, the Aspergillus flavus group has traditionally been used in Japan for the production of fermented foodstuffs such as "miso", soy sauce, and "sake." This mycotoxin has bacteriostatic activity (Lee et al., 1950) , and it has been shown to inhibit mushroom tyrosinase (Saruno et al., 1979) and polyphenoloxidases (PPO), for example purified from potato and white shrimp (Chen et al., 1991) . In addition, this tyrosinase inhibitor effectively inhibits the formation of DOPA from tyrosine in the process of melanine biosynthesis (Kahn, 1995) . Based on these effects, it has been used as an inhibitor of tyrosinase in foods and as a food additive to prevent enzymatic browning of raw crabs and shrimps due to PPO. Furthermore, it has increasingly been employed as a skin-depigmenting agent in cosmetics for its excellent whitening properties (Cabanas et al., 1994) .
Recently, Fujimoto et al. reported development of thyroid follicular cell adenomas in male and female B6C3F1 mice given a diet containing 1.5 or 3% kojic acid for 20 months (Fujimoto et al., 1998) . We also previously reported the tumorpromoting effects of kojic acid on development of thyroid proliferative lesions such as focal follicular hyperplasias and/or adenomas in rats initiated with N-bis(2-hydroxypropyl)nitrosamine (DHPN) when given in the diet at 2% for 12 weeks (Mitsumori et al., 1999) . The serum T3 and T4 levels were found to be markedly decreased in this group with pronounced elevation of the serum TSH, suggesting a role for continuous hormonal stimulation through the feedback mechanism of the pituitary-thyroid axis (Hill et al., 1989; McClain, 1992) . Based on these results, we concluded that thyroid follicular tumors might be induced in rats as well as in mice by continuous kojic acid administration. In order to elucidate the mechanisms underlying the decrease in thyroid hormones. In our previous study (Mitsumori et al., 1999) we measured the activity of liver T4-uridine diphosphate glucronosyltransferase (UDP-GT), which catalyzes thyroid hormones and plays a role in thyroid tumor promotion (Hill et al., 1989; McClain, 1989) . However, no enhancement was evident in the study.
The present study was performed to determine whether kojic acid influences iodide uptake or iodine organification in the thyroid, which is the synthetic pathway of thyroid hormones. In addition, attention was focused on thyroid histopathological changes.
in an air-conditioned room (room temperature, 23 Ϯ 2°C; relative humidity, 60 Ϯ 5°C; a 12-h light/12-h dark cycle). Pulverized basal diet (CRF-1, Oriental Yeast Co., Ltd., Tokyo) and tap water were provided ad libitum. Kojic acid (KA) was obtained from Nagase Biochemical Co. (Tokyo). After a one-week acclimatization period, animals without any abnormal findings were selected for the present study.
A total of 48 rats were divided into 6 groups consisting of 8 rats each. The initial mean body weights of each group were approximately equal. The rats in groups 2, 3, 4, 5, and 6 received basal diet containing 0.008% KA, 0.03% KA, 0.125% KA, 0.5% KA and 2% KA, respectively, for 4 weeks, while those in group 1 were given basal diet. The reason 2% KA was selected as the highest dose in the present study was as follows: in our preliminary study, increases in serum TSH in rats fed a diet containing 4% KA for 12 weeks were not as high as those in the 2% KA group, because of the severe toxicity of KA.
After the 4-week treatment, blood was collected from the abdominal aortas of 5 animals from each group under ether anesthesia, for hormone assays, followed by autopsy for histopathological examination. Amarex-MT3 and Amarex-MT4 assay kits (Oso Clinical Diagnostic Co., Tokyo) were employed to determine serum T3 and T4 concentrations. Serum TSH was measured with NIADDK reagents following the recommended protocol. The antigen was iodinized by the lactoperoxidase method. The second antibody, anti-rabbit IgG, was provided by the Institute for Molecular and Cellular Regulation at Gunma University (Maebashi-shi, Gunma-ken, Japan). The remainder of rats were sacrificed at the end of experiment, for measurement of 125 I uptake and its organification in the thyroid. Na 125 I (specific activity ϭ 579 Mbq/ml) was purchased from Amersham International (Buckinghamshire, U.K.). At 24 h before sacrifice, rats were injected intraperitoneally with 0.4 ml of 0.1 M Na 125 I in normal saline. Under ether anesthesia, their thyroids were removed, and the radioactivity was measured by NaI scintillation counter (Packard Instrument Co., U.S.A.) (Rapoport et al., 1976; Okuno et al., 1996) . To determine the organic formation ratios, the thyroid tissue was homogenized with 0.5 ml of 0.15 M NaCl-1 mM KI. An equal volume of 10% trichloroacetic acid was added, centrifugation performed at 800 ϫ g for 10 min, and the pellets resuspended in 5% trichloroacetic acid, before further centrifugation. Radioactivity of the final pellets was measured with a gamma counter as 125 I. The data were expressed as the organic formation ratio (%) of 125 I (Okuno et al., 1996) .
At autopsy, the weights of the thyroids and livers were recorded. Thyroid and pituitary tissues were fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned at 4 -5 m, and stained with hematoxylin and eosin for microscopic examination. In order to assess the responses of thyroid follicular epithelial cells, quantitative morphometrical analyses using a computer-assisted image analyzer, were performed to measure the severity of the thyroid follicular hypertrophy. The data were expressed as the ratio of the area of follicular epithelial cells to the area of the colloids.
All of the quantitative data in the present study were statistically evaluated using Bartlett's test for heterogenity of variance. If the variance was not heterogenous, standard one-way ANOVA was used. If there were significant differences among the means, Dunnet's or Scheffes tests were applied to determine which group was significantly different from the controls. If the variance was heterogeneous, the Kruskal-Wallis test and nonparametric Dunnet's or Scheffes tests were applied (Yamasaki et al., 1981) . Data for incidences of thyroid histopathological lesions were analyzed with the Fisher's exact test.
RESULTS
Although the total intake of diet in group 6, receiving 2% KA, was slightly lower than that in the control group (Table 1) , there were no significant intergroup differences in the final body weights. Absolute and relative weights of the thyroid were increased in a dose-dependent manner in all treated groups, significance being attained in the groups given 0.5% KA or more ( Table 2 ). The relative weight of the pituitary was significantly increased in the 2% KA group. The relative liver weights were significantly greater in all treated groups except for the 0.125% KA group. However, these alterations were not biologically significant, because there was neither significant difference in absolute weights nor dose-dependency in the relative weights.
While there were no statistically significant differences in serum T3 levels between the control group (0.606 Ϯ 0.085 ng/ml) and groups 2-5, it was significantly decreased in group 6 (0.364 Ϯ 0.129 ng/ml) ( Table 3) . Serum T4 levels were also significantly decreased in group 6 (1.71 Ϯ 0.41 mg/dl) as compared to those of the control group (3.70 Ϯ 0.27 mg/ml), and serum TSH was significantly increased (29.08 Ϯ 10.41 ng/ml) as compared to the control group (6.82 Ϯ 0.69 ng/ml). There were no other significant intergroup differences for these parameters, between the control group and groups 2-5.
Thyroid 125 I uptakes were clearly decreased in a dose-dependent manner in all treated groups, significance being attained for values in the groups given 0.03% KA or more (Table 4) . However, the organic 125 I-formation ratio was only significantly reduced in group 6 (39.7 Ϯ 10.7%), and there were no intergroup differences between the control group (73.5 Ϯ 5.1%) and groups 2-5 (Table 4) .
Incidence and quanititative morphometrical analysis data for thyroid lesions are given in Table 5 . None were observed in the control group (Fig. 1) or group 2. Both decreased colloid of follicles and follicular cell hypertrophy (Fig. 2) were observed at high incidences in groups 3-6, the incidences being significantly increased. In addition, thyroid capsular fibrosis was observed in all rats of group 6. The ratio of the area of follicular epithelial cells to the area of the colloids was significantly increased in the groups given 0.03% KA or more.
DISCUSSION
We previously reported that continuous administration of KA promotes the development of thyroid focal proliferative lesions such as focal follicular hyperplasias and/or adenomas, in a two-stage thyroid tumorigenesis model, in rats initiated with N-bis(2-hydroxypropyl) nitrosamine (DHPN). We concluded that stimulation due to elevated serum TSH was responsible (Mitsumori et al., 1999) . Generally, TSH from the pituitary gland plays an important role in enhancement of thyroid tumor development, and its production and release are controlled by thyroid hormone levels in blood, via the negative feedback mechanism of the pituitary-thyroid axis (Hill et al., 1989; McClain, 1992) . Many factors are related to decrease of circulating thyroid hormone levels. For example, inhibition of iodide transport into the thyroid, iodide oxidation, iodine organification or coupling catalyzed by thyroid peroxidase, or hormone inactivation by hepatic microsomal enzymes such as T4-UDP-GT can all cause thyroid hormone level reduction (Bater and Klassen, 1994; McClain, 1989) . In our previous study, we focused on the catabolism of thyroid hormones in the liver. However, no clear enhancement of activity of the liver T4-UDP-GT, responsible for T4 clearance, was observed.
We therefore focused on intrathyroid iodine metabolism in the present study. In the 2% KA group, iodide uptake and iodine organification were markedly inhibited and serum T3 and T4 levels were significantly decreased. Moreover, elevation of serum TSH levels, increased thyroid weights, and thyroid follicular cell hypertrophy were observed. Our results thus support the conclusion that thyroid tumors caused by KA administration are probably induced by non-genotoxic mechanisms, although positive results for KA in several mutagenicity studies in vitro have been reported (Shibuya et al., 1982;  Wei et al., 1991; Wehner et al., 1978) . However, a question thus arises as to why serum levels of T3/T4 and TSH were not altered in lower-dose groups. In contrast to the fluctuations of thyroid-related hormones, thyroid weights were significantly increased in the groups receiving 0.5% KA or more, and follicular cell hypertrophy and decreased colloids were evident in the groups receiving 0.03% KA or more. In addition, iodide uptake was also decreased in the groups receiving 0.03% KA or more. Based on these findings, there might be a possibility that thyroidal functions for hormone production and serum TSH levels were also transiently altered in the lower dose groups. However, the reason why such alterations were not observed in the lower-dose groups might be attributable to the phenomenon that the thyroid hormone and TSH levels in serum were balanced in the lower groups because of thyroid autoregulation and/or homeoatasis (Pisarev et al., 1985) . In the time course observation study carried out to determine the alterations of thyroid hormone levels in rats given repeated administration of goitrogenic agents, it was reported that reduction of T4 and elevation of TSH levels were obvious in the early phase of the treatment but not in the late stage (Mitsumori et al., 1995) . Such a time-course fluctuation of serum thyroid hormones should also be taken into account. The first step in the synthesis of thyroid hormones is the uptake of iodide Ϫ from the extracellular fluid by thyroid follicular cells. The iodide is concentrated in the follicular cells by an active transport mechanism, the so-called "iodide pump" (Taurog, 1978) , which is energy consuming, connected to a Na ϩ -K ϩ ATPase activity and stimulated by TSH. A number of anions, such as perchlorate (ClO4 Ϫ ) or perrhenate (ReO4 Ϫ ), competitively inhibit the active transport of iodide and themselves become concentrated in the thyroid (Hill et al., 1989; Taurog, 1978) . When iodine intake is normal or low, these anions inhibit iodine accumulation so markedly that goiter and hypothyroidism result. They can also inhibit the organic iodination but the doses necessary to produce effects are much higher than those which inhibit iodide transport (Greer et al., 1966) . Continuous administration of potassium perchlorate (KClO4) induces thyroid adenomas and carcinomas in rats initiated with DHPN (Hiasa et al., 1987) . Thiocyanate (SCN Ϫ ) is also a potent inhibitor of iodide transport, acting as a competitor but without being concentrated in the thyroid and not inhibiting TSH-mediated cAMP production or Na ϩ -K ϩ ATPase activity (Hill et al., 1989; Taurog, 1978) . In addition, SCN Ϫ is a competitive substrate for the thyroid peroxidase and inhibits organic iodination at doses only slightly greater than those which influence iodide transport (Fukayama et al., 1992) . Chronic administration of potassium thiocyanate (KSCN) causes colloid goiter in rats and promotes thyroid tumorigenesis through TSH stimulation in DHPN-initiated rats (Kanno et al., 1990) . In the present experiment, inhibition of 125 I uptake was observed in a dose-dependent manner. In contrast, significant decrease of the organic-formation ratio was only observed in the 2% KA group. Based on the literature and our results, we conclude that KA probably acts as an inhibitor of iodide transport. Although it is unclear whether KA has any potential to inhibit organic iodination like KCN Ϫ or other anti-thyroid substances, the reduction of iodine organification was possibly secondary to a lack of iodide.
In an iodine-deficient condition, the thyroid makes greater concentrations of iodide Ϫ , transported from the extracellular fluid, with or without TSH (Chopra et al., 1978) . Iodinedeficient diets produce enlargement of the thyroid, increase in monoiodotyrosine/diiodotyrosine, and progressive increase in the T3/T4 molar ratio (Fukuda, 1985) , because T3, containing only 75% as much iodine as T4, has 10 times higher an affinity for thyroid hormone receptor in target cells and for hormonal activity (Martin et al., 1985) . In experiments with severely iodine-deficient rats, reduction of both serum T3 and T4 levels has been observed. Serum T3, on the other hand, remained almost within the normal range in moderately iodine-deficient rats (Fukuda et al., 1975; Garcilaso et al., 1997) . Our observation of no-statistically-significant differences or dose dependency in serum T3 levels of the groups given up to 0.125% KA, despite decreases in 125 I uptake, is thus in agreement with the literature. Therefore, adaptation of the thyroid presumably occurs with production and release of serum TSH maintained in normal ranges at doses of 0.5% KA or less. It might be expected that reduction of serum T4 and T3 levels and elevation of serum TSH would be induced by prolonged KA administration, and further investigations of time-course changes are needed to clarify this point. It is unclear whether the increase of thyroid weights and follicular cell hypertrophy observed in the low-dose groups without TSH elevation are adaptations to the slight inhibition of iodide transport or the consequence of increased sensitivity to TSH caused by the thyroid TSH receptor autoregulation for inhibition of iodine organification (Pisarev et al., 1985) and other growth factors such as epidermal growth factor (EGF) or insulin-like growth factor (IGF), which modulate thyroid function and may play an important role in promotion of thyroid proliferative lesions (Polychronakos et al., 1986; Smith et al., 1986; Tell et al., 1978) . Further studies are also needed to clarify the overall picture of the effects of KA on thyroid function and thyroid tumor promotion.
FIG. 1.
Thyroid in a rat in the control group. H-E stain, magnification ϫ87.
FIG. 2.
Thyroid follicles consisting of decreased colloid and hypertrophic thyroid follicular epithelial cells in a rat given diet containing 2% KA for 4 weeks. Thyroid capsular fibrosis was also observed. H-E stain, magnification ϫ87.
